Cargando…
The evolution of the nasopharyngeal carcinoma staging system over a 10-year period: implications for future revisions
BACKGROUND: The classification criteria and staging groups for nasopharyngeal carcinoma described in the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) staging system have been revised over time. This study assessed the proportion of patients whose staging and...
Autores principales: | Tang, Si-Qi, Mao, Yan-Ping, Xu, Cheng, Guo, Rui, Li, Wen-Fei, Tang, Ling-Long, Sun, Ying, Ma, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478675/ https://www.ncbi.nlm.nih.gov/pubmed/32810045 http://dx.doi.org/10.1097/CM9.0000000000000978 |
Ejemplares similares
-
Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma
por: Du, Xiao-Jing, et al.
Publicado: (2016) -
Changes in Disease Failure Risk of Nasopharyngeal Carcinoma over Time: Analysis of 749 Patients with Long-Term Follow-Up
por: Liu, Xu, et al.
Publicado: (2017) -
Implication of comorbidity on the initiation of chemotherapy and survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma
por: Guo, Rui, et al.
Publicado: (2016) -
Association of delayed chemoradiotherapy with elevated Epstein-Barr virus DNA load and adverse clinical outcome in nasopharyngeal carcinoma treatment during the COVID-19 pandemic: a retrospective study
por: Huang, Cheng-Long, et al.
Publicado: (2022) -
Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period
por: Huang, Huageng, et al.
Publicado: (2023)